Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.

被引：0

作者：

Qazilbash, MH ^{[1
]}

Davis, MS ^{[1
]}

Ana, A ^{[1
]}

Roden, L ^{[1
]}

Libunao, F ^{[1
]}

Tball, PF ^{[1
]}

Wang, XM ^{[1
]}

Couriel, D ^{[1
]}

De Lima, M ^{[1
]}

Hosing, C ^{[1
]}

Kebriaei, P ^{[1
]}

Weber, D ^{[1
]}

Wang, M ^{[1
]}

Jones, RB ^{[1
]}

Matthes, SG ^{[1
]}

Champlin, RE ^{[1
]}

Giralt, SA ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1159

引用

页码：338A / 339A

页数：2

共 50 条

[1] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma.
Qazilbash, Muzaffar H.
Saliba, Rima M.
Davis, Marilyn S.
Mendoza, Floralyn L.
Hosing, Chitra
Couriel, Daniel R.
De Lima, Marcos
Kebriaei, Partow
Weber, Donna M.
Wang, Michael
Alousi, Arnin M.
Matthes, Steven G.
Jones, Roy B.
Champlin, Richard E.
Giralt, Sergio A.
BLOOD, 2006, 108 (11) : 881A - 881A
[2] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma
Qazilbash, M. H.
Jindani, S.
Gul, Z.
Saliba, R.
Hosing, C.
Mendoza, F.
Qureshi, S. P.
Weber, D. M.
Wang, M.
Flosser, T.
Couriel, D. P.
Kebriaei, P.
Popat, U.
Alousi, A. M.
De Lima, M.
Champlin, R. E.
Giralt, S. A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 9 - 10
[3] Velcade and high-dose melphalan: a new preparative regimen before autologous stem cell transplantation for multiple myeloma
Danho, C
Huynh, A
Roussel, M
Ysebaert, L
Recher, C
Huguet, FR
Nouvel, C
Laurent, G
Attal, M
BONE MARROW TRANSPLANTATION, 2006, 37 : S137 - S137
[4] Bortezomib With High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid In a Preparative Regimen For Multiple Myeloma: 5-Year Follow Up
Cornelison, A. Megan
Dinh, Yvonne
Sharma, Manish
Shah, Nina
Bashir, Qaiser
Parmar, Simrit
Hosing, Chitra M.
Popat, Uday R.
Champlin, Richard E.
Qazilbash, Muzaffar H.
BLOOD, 2013, 122 (21)
[5] High-dose topotecan, melphalan and cyclophosphamide (TMC): A new regimen for autologous transplantation in multiple myeloma.
Donato, ML
Champlin, RE
Weber, DM
Alexanian, R
Ippoliti, C
Aleman, AS
Cooke, SS
Martin, TG
de Lima, MJ
Giralt, SA
BLOOD, 2000, 96 (11) : 798A - 798A
[6] High-dose melphalan and etoposide prior to autologous hematopoietic stem cell transplant is an effective regimen in the treatment of multiple myeloma.
Briggs, AD
Taylor, CW
Sturm, TJ
Shapiro, TW
List, AF
BLOOD, 1998, 92 (10) : 362B - 362B
[7] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
Bernasconi, P
Alessandrino, EP
Colombo, AA
Caldera, D
Bonfichi, M
Martinelli, G
Malcovati, L
Varettoni, M
Maiocchi, M
Brusamolino, E
Pagnucco, G
Castagnola, C
Corso, A
Bernasconi, C
BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
[8] Feasibility of high dose busulfan and melphalan with autologous hematopoietic stem cell transplantation in multiple myeloma.
Begum, U
Fitzgerald, D
Yong, LO
Grand, M
Thomas, U
Chen, Y
Patel, A
Goodman, D
Dillon, C
Amorosi, E
Cook, P
BLOOD, 1997, 90 (10) : 4346 - 4346
[9] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Rodriguez, Tulio E.
Hari, Parameswaran
Stiff, Patrick J.
Smith, Scott E.
Sterrenberg, Danielle
Vesole, David H.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
[10] High dose topotecan plus melphalan: A safe and tolerable preparative regimen for autologous transplantation in multiple myeloma.
Holman, PR
Bashey, A
Corringham, SM
Carrier, E
O'Quigley, J
Ball, E
BLOOD, 1999, 94 (10) : 578A - 578A

← 1 2 3 4 5 →